SCHEMBL10813829

SCHEMBL10813829

COC(=O)OCCCOC(OC(=O)OC)n1cnc2c(N)ncnc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.45
▸ ADORA2B P29275 2/20 0.45
▸ ADORA1 P30542 2/20 0.45
▸ PI4KA P42356 1/20 0.45
▸ PI4K2B Q8TCG2 1/20 0.45
▸ PI4K2A Q9BTU6 1/20 0.45
▸ PI4KB Q9UBF8 1/20 0.45
▸ ADCY5 O95622 1/20 0.43
▸ AHCY P23526 4/20 0.43
▸ ADA P00813 4/20 0.42
▸ PDE2A O00408 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10817431 0.90 ADA (0.47) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL10818132 0.88 ADORA2A (0.48) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL9583879 0.85 ADORA2A (0.48) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL9583596 0.78 ADA (0.41) ADORA2AADORA2BADORA1AHCYADA
SCHEMBL10817902 0.78 KDM4E (0.42) KDM4EALDH1A1HSD17B10
SCHEMBL10814378 0.77 CCNB2 (0.43) ADORA1ADAPDE2ACYP3A4PDE4A
SCHEMBL10816711 0.74 CYP1A2 (0.37) ADAPDE2ACYP3A4PDE4APDE4B
SCHEMBL10816337 0.74 CYP1A2 (0.43) ADAPDE2ACYP3A4PDE4APDE4B
SCHEMBL9583170 0.72 CDK1 (0.47) KDM4EALDH1A1HSD17B10
SCHEMBL10818088 0.72 CDC20 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP claimed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP claimed
Send feedback